Antimicrobial treatment of asymptomatic carriers of verocytotoxin-producing Escherichia coli: An empiric study
- 1 January 2005
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 37 (1) , 61-63
- https://doi.org/10.1080/00365540510026427
Abstract
Antimicrobial treatment of acute infection caused by verocytotoxin toxin-producing Escherichia coli (VTEC) is controversial due to risk of inducing haemolytic uraemic syndrome. We review the treatment of 9 persons who experienced serious social problems due to prolonged, asymptomatic carriage of non-O157 VTEC. Eradication of VTEC was successful and without complications.Keywords
This publication has 5 references indexed in Scilit:
- Virulence Factors for Hemolytic Uremic Syndrome, Denmark1Emerging Infectious Diseases, 2004
- Effects of Azithromycin on Shiga Toxin Production by Escherichia coli and Subsequent Host Inflammatory ResponseAntimicrobial Agents and Chemotherapy, 2002
- Escherichia coliHarboring Shiga Toxin 2 Gene Variants: Frequency and Association with Clinical SymptomsThe Journal of Infectious Diseases, 2002
- The Role of Virulence Factors in Enterohemorrhagic Escherichia coli (EHEC) - Associated Hemolytic-Uremic SyndromeSeminars in Thrombosis and Hemostasis, 2001
- DiarrheagenicEscherichia coliClinical Microbiology Reviews, 1998